Annual ROA
-164.06%
-71.48%-77.21%
31 December 2023
Summary:
Spyre Therapeutics annual return on assets is currently -164.06%, with the most recent change of -71.48% (-77.21%) on 31 December 2023. During the last 3 years, it has fallen by -115.60% (-238.55%). SYRE annual ROA is now -461.46% below its all-time high of -29.22%, reached on 01 December 2015.SYRE ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROA
-50.97%
-0.46%-0.91%
30 September 2024
Summary:
Spyre Therapeutics quarterly return on assets is currently -50.97%, with the most recent change of -0.46% (-0.91%) on 30 September 2024. Over the past year, it has increased by +109.38% (+68.21%). SYRE quarterly ROA is now -92.63% below its all-time high of -26.46%, reached on 01 December 2015.SYRE Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SYRE ROA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +68.2% |
| 3 y3 years | -238.6% | -10.2% |
| 5 y5 years | -68.7% | +34.0% |
SYRE ROA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -238.6% | at low | -10.2% | +78.8% |
| 5 y | 5 years | -238.6% | at low | -24.1% | +78.8% |
| alltime | all time | -461.5% | +53.5% | -92.6% | +85.6% |
Spyre Therapeutics ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -50.97%(+0.9%) |
| June 2024 | - | -50.51%(-55.6%) |
| Mar 2024 | - | -113.80%(-29.0%) |
| Dec 2023 | -164.06%(+77.2%) | -160.35%(-21.8%) |
| Sept 2023 | - | -205.04%(-14.9%) |
| June 2023 | - | -241.03%(+151.0%) |
| Mar 2023 | - | -96.04%(+6.0%) |
| Dec 2022 | -92.58%(+91.0%) | - |
| Dec 2022 | - | -90.61%(+10.4%) |
| Sept 2022 | - | -82.09%(+8.0%) |
| June 2022 | - | -75.99%(+33.5%) |
| Mar 2022 | - | -56.91%(+23.0%) |
| Dec 2021 | -48.46%(-26.7%) | -46.26%(+2.9%) |
| Sept 2021 | - | -44.97%(+9.5%) |
| June 2021 | - | -41.08%(-26.6%) |
| Mar 2021 | - | -55.93%(-11.8%) |
| Dec 2020 | -66.09%(-32.0%) | -63.38%(-8.3%) |
| Sept 2020 | - | -69.09%(-10.6%) |
| June 2020 | - | -77.27%(-4.3%) |
| Mar 2020 | - | -80.77%(+4.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | -97.26%(+46.7%) | -77.17%(+6.6%) |
| Sept 2019 | - | -72.36%(+10.8%) |
| June 2019 | - | -65.30%(-0.4%) |
| Mar 2019 | - | -65.59%(-1.0%) |
| Dec 2018 | -66.28%(+49.8%) | -66.27%(+17.1%) |
| Sept 2018 | - | -56.61%(+11.2%) |
| June 2018 | - | -50.91%(+3.1%) |
| Mar 2018 | - | -49.37%(+13.1%) |
| Dec 2017 | -44.24%(+7.8%) | -43.64%(+9.1%) |
| Sept 2017 | - | -39.99%(+12.1%) |
| June 2017 | - | -35.67%(-4.5%) |
| Mar 2017 | - | -37.35%(+0.1%) |
| Dec 2016 | -41.05%(+40.5%) | -37.33%(-1.8%) |
| Sept 2016 | - | -38.02%(+4.7%) |
| June 2016 | - | -36.32%(+10.0%) |
| Mar 2016 | - | -33.03%(+24.8%) |
| Dec 2015 | -29.22%(-91.7%) | -26.46%(-14.8%) |
| Sept 2015 | - | -31.07%(-6.8%) |
| June 2015 | - | -33.34%(-30.2%) |
| Mar 2015 | - | -47.78%(-86.5%) |
| Dec 2014 | -353.14% | -353.14% |
FAQ
- What is Spyre Therapeutics annual return on assets?
- What is the all time high annual ROA for Spyre Therapeutics?
- What is Spyre Therapeutics quarterly return on assets?
- What is the all time high quarterly ROA for Spyre Therapeutics?
- What is Spyre Therapeutics quarterly ROA year-on-year change?
What is Spyre Therapeutics annual return on assets?
The current annual ROA of SYRE is -164.06%
What is the all time high annual ROA for Spyre Therapeutics?
Spyre Therapeutics all-time high annual return on assets is -29.22%
What is Spyre Therapeutics quarterly return on assets?
The current quarterly ROA of SYRE is -50.97%
What is the all time high quarterly ROA for Spyre Therapeutics?
Spyre Therapeutics all-time high quarterly return on assets is -26.46%
What is Spyre Therapeutics quarterly ROA year-on-year change?
Over the past year, SYRE quarterly return on assets has changed by +109.38% (+68.21%)